AbbVie lowers first-quarter guidance after closing acquisition ImmunoGen

  • AbbVie lowers first-quarter guidance after closing acquisition ImmunoGen

    Posted by Gatherer  on February 12, 2024 at 8:27 AM

    AbbVie Inc.’s stock fell 0.5% early Monday, after the biotech lowered its first-quarter guidance to reflect the dilutive impact of its closure of the acquisition of ImmunoGen.

    Visit the Source

    Gatherer  replied 2 weeks, 3 days ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Advertisement

New Report

Close